About Inovio Pharmaceuticals, Inc.
A DNA-medicines biotech developing vaccines and immuno-oncology treatments. No dividend, high beta, pre-revenue with binary clinical trial risk. Premiums appear rich but gap-down potential on trial failures is severe — position sizing is everything.
Biotechnology